Wells Fargo & Company Nautilus Biotechnology, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 26,032 shares of NAUT stock, worth $62,476. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,032
Previous 21,706 19.93%
Holding current value
$62,476
Previous $50,000 48.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$2.24 - $3.08 $9,690 - $13,324
4,326 Added 19.93%
26,032 $74,000
Q2 2024

Aug 13, 2024
BUY
$2.22 - $3.0 $7,914 - $10,695
3,565 Added 19.65%
21,706 $50,000
Q1 2024

May 10, 2024
BUY
$2.41 - $3.18 $5,521 - $7,285
2,291 Added 14.45%
18,141 $53,000
Q4 2023

Feb 09, 2024
BUY
$2.34 - $3.39 $7,183 - $10,407
3,070 Added 24.02%
15,850 $47,000
Q3 2023

Nov 13, 2023
SELL
$2.87 - $3.94 $19,372 - $26,595
-6,750 Reduced 34.56%
12,780 $40,000
Q2 2023

Aug 15, 2023
BUY
$2.21 - $4.52 $23,733 - $48,540
10,739 Added 122.16%
19,530 $75,000
Q1 2023

May 12, 2023
BUY
$1.67 - $2.77 $14,179 - $23,520
8,491 Added 2830.33%
8,791 $24,000
Q4 2022

Feb 13, 2023
SELL
$1.55 - $2.47 $212 - $338
-137 Reduced 31.35%
300 $0
Q3 2022

Nov 14, 2022
SELL
$1.96 - $3.13 $964 - $1,539
-492 Reduced 52.96%
437 $1,000
Q2 2022

Aug 12, 2022
BUY
$2.64 - $4.84 $1,660 - $3,044
629 Added 209.67%
929 $3,000
Q4 2021

Feb 14, 2022
SELL
$4.45 - $6.21 $1,388 - $1,937
-312 Reduced 50.98%
300 $2,000
Q3 2021

Nov 15, 2021
BUY
$6.14 - $10.1 $1,915 - $3,151
312 Added 104.0%
612 $4,000
Q2 2021

Aug 16, 2021
BUY
$9.04 - $14.19 $2,711 - $4,257
300 New
300 $3,000

Others Institutions Holding NAUT

# of Institutions
86
Shares Held
64.3M
Call Options Held
1.9K
Put Options Held
100
View Full List

About Nautilus Biotechnology, Inc.

NAUT Quotes by TradingView
  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $299M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email